Unknown

Dataset Information

Hormone Therapy for Cancer Is a Risk Factor for Relapse of Inflammatory Bowel Diseases.


ABSTRACT:

Background & aims

Exposure to hormone contraception has been associated with an increased risk of relapse of inflammatory bowel diseases (IBDs). Little is known about the effects of cancer therapies, specifically hormone therapies, on the course of IBD.

Methods

We conducted a retrospective cohort study, collecting data from 5 medical centers, on patients with IBD who received a subsequent diagnosis of breast or prostate cancer from 1997 through 2018. For patients with quiescent IBD at their cancer diagnosis, the primary outcome was relapse of IBD. For patients with active IBD at their cancer diagnosis, the primary outcome was IBD remission.

Results

Our analysis included 447 patients with IBD (44% with Crohn's disease, 53% with ulcerative colitis, and 3% with IBD uncla

SUBMITTER: Axelrad JE 

PROVIDER: S-EPMC7354097 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature